Why Is AstraZeneca Stock Trading Lower On Tuesday? biztoc.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from biztoc.com Daily Mail and Mail on Sunday newspapers.
AstraZeneca's TROPION-Lung01 phase 3 trial for datopotamab deruxtecan in NSCLC showed OS improvement in nonsquamous patients. While the overall trial did not reach statistical significance.
/PRNewswire/ The global lung cancer therapeutics market size is estimated to grow by USD 10.52 billion from 2024-2028, according to Technavio. The market is.
/PRNewswire/ Allied Market Research has recently published a report, titled, "Degenerative Disc Disease Treatment Market Size, Share, Competitive Landscape.
Tango Therapeutics halts its TNG348 program due to liver toxicity issues found in dose escalation studies. The company will now focus on its PRMT5 program and plans to update on TNG908 and TNG462 later this year.